CTLA4-Ig Abatacept Ameliorates Proteinuria by Regulating Circulating Treg/IL-17 in Adriamycin-Induced Nephropathy Rats
Open Access
- 27 April 2020
- journal article
- research article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2020, 1-9
- https://doi.org/10.1155/2020/2347827
Abstract
Objective. This study is aimed at investigating the efficacy of CTLA4-Ig abatacept in normalizing proteinuria and its possible mechanism in adriamycin-induced nephropathy (AIN) rats. Methods. A total of 32 healthy male Sprague-Dawley rats were randomly divided into a normal group, an AIN group, an abatacept group, and a prednisone group. Adriamycin (6.5mg/kg) was injected once via the tail vein of rats to induce nephrotic syndrome. After adriamycin treatment, the abatacept group rats were given abatacept (0.5mg/kg) once by intraperitoneal injection on day 14. In addition, the prednisone group rats were given prednisone (12.5mg/kg) daily consecutively by gavage from day 14 to day 21. Blood, urine, and kidney tissue specimens were collected when sacrificed on day 21. The 24-hour urinary protein, serum albumin, cholesterol, creatinine, and urea nitrogen were then detected. An enzyme-linked immunosorbent assay was used to determine the level of urine CD80 and serum IL-17. Flow cytometry was used to investigate the prevalence of circulating Treg. Hematoxylin-eosin staining and electron microscopy were used for a renal histological study. Immunofluorescence staining was performed to confirm the CD80 expression of renal tissue. Results. The 24-hour urinary protein of the abatacept group was significantly lower than that of the prednisone group and the AIN group. The level of urine CD80 of the abatacept group was significantly lower than that of the AIN group. Compared with the AIN group and the prednisone group, the circulating Treg prevalence of the abatacept group was significantly higher, while the level of serum IL-17 was lower. A negative kidney staining of CD80 expression was demonstrated in each group in this study. The 24-hour urinary protein had a negative correlation with the circulating Treg prevalence and Treg/IL-17 and a positive correlation with the urine CD80 and serum IL-17. Urinary CD80 had a positive correlation with serum IL-17 and no correlation with the circulating Treg prevalence. Conclusions. CTLA4-Ig abatacept can reduce proteinuria of adriamycin-induced nephropathy rats, possibly at least partially as a result of regulating circulating Treg/IL-17. CTLA4-Ig abatacept could be a promising regimen for idiopathic nephrotic syndrome.Keywords
Funding Information
- Central South University
This publication has 37 references indexed in Scilit:
- An obligate cell-intrinsic function for CD28 in TregsJCI Insight, 2013
- Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF- B-dependent pathwayNephrology Dialysis Transplantation, 2011
- Minimal change disease: a “two-hit” podocyte immune disorder?Pediatric Nephrology, 2010
- Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosisKidney International, 2010
- The prevalence of Th17 cells and FOXP3 regulate T cells (Treg) in children with primary nephrotic syndromePediatric Nephrology, 2009
- Urinary CD80 Excretion Increases in Idiopathic Minimal-Change DiseaseJournal of the American Society of Nephrology, 2009
- Induction of T Regulatory Cells Attenuates Idiopathic Nephrotic SyndromeJournal of the American Society of Nephrology, 2009
- THE B7 FAMILY REVISITEDAnnual Review of Immunology, 2005
- LONG-TERM OUTCOME FOR CHILDREN WITH MINIMAL-CHANGE NEPHROTIC SYNDROMEThe Lancet, 1985
- PATHOGENESIS OF LIPOID NEPHROSIS: A DISORDER OF T-CELL FUNCTIONThe Lancet, 1974